Tag: ACTIV-3
Covid-19 investigational therapeutics to be analysed in big clinical trials
Covid-19 investigational therapeutics are to be evaluated in large clinical trials. Two controlled, randomized Phase 3 clinical trials have started evaluating investigational monoclonal antibodies...
